共 50 条
- [41] Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patientsINTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (11) : 952 - 959Tomita, YoshihikoTatsugami, KatsunoriNakaigawa, NoboruOsawa, TakahiroOya, MototsuguKanayama, HiroomiKondoh, Chihiro NakayamaSassa, NaotoNishimura, KazuoNozawa, MasahiroMasumori, NaoyaMiyoshi, YasuhideKuroda, ShingoTanaka, ShingoKimura, AkikoTamada, Satoshi
- [42] Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT)CLINICAL CANCER RESEARCH, 2019, 25 (18) : 5485 - 5492Okada, MorihitoKijima, TakashiAoe, KeisukeKato, TerufumiFujimoto, NobukazuNakagawa, KazuhikoTakeda, YuichiroHida, ToyoakiKanai, KuninobuImamura, FumioOizumi, SatoshiTakahashi, ToshiakiTakenoyama, MitsuhiroTanaka, HiroshiHirano, JunNamba, YoshinobuOhe, Yuichiro
- [43] Efficacy and safety of JMT103 in patients with giant cell tumor of bone: A multicenter, single-arm, open-label, phase Ib/II study.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Niu, XiaohuiWei, FengTu, ChongqiHuang, GangBi, WenzhiLi, JianminYao, WeitaoZhang, XiaojingShen, JingnanZhang, GuochuanYan, WangjunYang, JilongLin, JianhuaYe, ZhaomingWang, DongGuo, ZhengTong, ZhichaoZhou, YuhongXu, HairongLi, Tao
- [44] Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular carcinoma: An open-label, single-arm, phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Bai, XueliChen, YiwenZhang, JunleiHu, WendiLi, XiangShen, YanZhang, MinWu, JianGao, ShunliangYu, JunQue, RishengZhang, YunYang, FuchunXia, WeiliangZhang, AibinTang, XiaofengLiang, Tingbo
- [45] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trialSIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)Chen, YuxiPan, YuanXie, YanyanShi, YuxunLu, YaoXia, YiwenSu, WenruChen, XiaoqingLi, ZuoyiWang, MinzhenMiao, SiyuYang, YatingJin, ChenjinLuo, GuangweiLong, ShixianXiao, HuiHuang, ChuangxinZhang, JianLiang, Dan
- [46] A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naive Metastatic Prostate CancerCLINICAL CANCER RESEARCH, 2020, 26 (05) : 990 - 999Corn, Paul G.Zhang, MiaoNogueras-Gonzalez, Graciela M.Xiao, LianchunZurita, Amado J.Subudhi, Sumit K.Tu, Shi-MingAparicio, Ana M.Coarfa, CristianRajapakshe, KimalHuang, ShixiaNavone, Nora M.Lin, Sue-HwaWang, GuocanRamachandran, SumankalaiTitus, Mark A.Panaretakis, TheocharisGallick, Gary E.Efstathiou, EleniTroncoso, PatriciaLogothetis, Christopher
- [47] Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD studyBMJ OPEN, 2020, 10 (03):Dane, FaysalOzgurdal, KirhanYalcin, SuayibBenekli, MustafaAykan, Nuri FarukYucel, IdrisOzkan, MetinEvrensel, TurkkanSevinc, AlperCoskun, Hasan SenolSanli, Ulus AliKara, Ismail OguzYumuk, Perran Fulden
- [48] PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 studyPROSTATE, 2020, 80 (01): : 99 - 108Petrylak, Daniel P.Vogelzang, Nicholas J.Chatta, KamalFleming, Mark T.Smith, David C.Appleman, Leonard J.Hussain, ArifModiano, ManuelSingh, ParminderTagawa, Scott T.Gore, IraMcClay, Edward F.Mega, Anthony E.Sartor, A. OliverSomer, BradleyWadlow, RaymondShore, Neal D.Olson, William C.Stambler, NancyDiPippo, Vincent A.Israel, Robert J.
- [50] Evaluation of safety and efficacy of intravenous zanamivir in the treatment of hospitalized Japanese patients with influenza: an open-label, single-arm studyANTIVIRAL THERAPY, 2015, 20 (04) : 415 - 423Watanabe, AkiraYates, Phillip J.Murayama, MarieSoutome, ToruFurukawa, Hiroiku